Price target upside
Theravance Biopharma, Inc. - Ordinary Shares Price Target Upside or Downside
TBPH price target upside based on the current price and analyst average.
Direct answer
Theravance Biopharma, Inc. - Ordinary Shares's analyst target implies +4.2%.
The average target is $17.67 compared with a recorded current price of $16.95.
This percentage is calculated from the verified average target and recorded market price.
Forecast evidence checked August 14, 2026.
Get free Theravance Biopharma, Inc. - Ordinary Shares email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $16.95
- Average price target
- $17.67
- High price target
- $19.00
- Low price target
- $17.00
- Target upside
- +4.2%
- Consensus rating
- none
- Analysts
- 3
- Evidence date
- August 14, 2026
- Valid through
- August 21, 2026